Welcome to LookChem.com Sign In|Join Free
  • or
2-Butanol, 1-(dimethylamino)-, (R)-, also known as (R)-1-(dimethylamino)-2-butanol or (R)-N,N-dimethyl-2-butanamine, is a chiral amine derivative with the molecular formula C6H15NO. It is a colorless liquid with a characteristic amine-like odor and is soluble in water and organic solvents. 2-Butanol, 1-(dimethylamino)-, (R)- is an enantiomer of 1-(dimethylamino)-2-butanol, with the (R)-configuration indicating the spatial arrangement of the dimethylamino group relative to the chiral center. It is used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals, owing to its unique reactivity and stereochemistry. The compound is also known for its potential applications in the field of asymmetric catalysis and as a chiral ligand in various chemical transformations.

3760-97-2

Post Buying Request

3760-97-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3760-97-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3760-97-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,7,6 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3760-97:
(6*3)+(5*7)+(4*6)+(3*0)+(2*9)+(1*7)=102
102 % 10 = 2
So 3760-97-2 is a valid CAS Registry Number.

3760-97-2Downstream Products

3760-97-2Relevant academic research and scientific papers

KRAS G12C INHIBITORS

-

Paragraph 0302-0303, (2019/05/24)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

KRAS G12C INHIBITORS

-

Paragraph 0183, (2017/12/18)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3760-97-2